| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/30/2009 | US20090192096 2'-Substituted 1,1'-Biphenyl-2-Carboxamides, Processes For Their Preparation, Their Use As Medicaments, And Pharmaceutical Preparations Comprising Them |
| 07/30/2009 | US20090192095 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/30/2009 | US20090192094 Treatment of diseases using ice inhibitors |
| 07/30/2009 | US20090192093 Abuse-resistant amphetamine prodrugs |
| 07/30/2009 | US20090192091 Peptide inhibitors of protein kinase C |
| 07/30/2009 | US20090192090 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192086 Identification of a novel bhd gene |
| 07/30/2009 | US20090192085 FKBP-L And Uses Thereof |
| 07/30/2009 | US20090192084 Compositions and method of treating hypoxia-associated diseases |
| 07/30/2009 | US20090192083 Methods and compositions for the treatment of gastrointestinal disorders |
| 07/30/2009 | US20090192082 Cxcr4 antagonist treatment of hematopoietic cells |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192080 Cerberus/coco derivatives and uses thereof |
| 07/30/2009 | US20090192079 Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen |
| 07/30/2009 | US20090192078 Methods for diagnosis of cardiovascular disease |
| 07/30/2009 | US20090192077 North-2'deoxy -methanocarbathymidines as antiviral agents for treatment of kaposi's sarcoma-associated herpes virus |
| 07/30/2009 | US20090192076 Recombinant vwf formulations |
| 07/30/2009 | US20090192075 Amylin Formulations |
| 07/30/2009 | US20090192074 Methods and pharmaceutical compositions for healing wounds |
| 07/30/2009 | US20090192073 Method for producing insulin analogs having a dibasic b chain terminus |
| 07/30/2009 | US20090192072 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 07/30/2009 | US20090192071 Use of photodynamic therapy to enhance treatment with immuno-modulating agents |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191570 Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191276 Colloidosomes having tunable properties and methods for making colloidosomes having tunable properties |
| 07/30/2009 | US20090191268 Allergy vaccines |
| 07/30/2009 | US20090191263 Compositions and methods for sirna inhibition of hif-1 alpha |
| 07/30/2009 | US20090191259 Efficient liposomal encapsulation |
| 07/30/2009 | US20090191255 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 07/30/2009 | US20090191253 Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated Pathologies |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191230 Cascade |
| 07/30/2009 | US20090191228 Immunogenic compositions capable of activating T-cells |
| 07/30/2009 | US20090191226 Adjuvant formulation comprising a submicron oil droplet emulsion |
| 07/30/2009 | US20090191224 Nucleolin-Mediated Cancer Diagnostics and Therapy |
| 07/30/2009 | US20090191223 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 07/30/2009 | US20090191216 Antibody or a fragment thereof, having neutralizing activity against HIV |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191207 Compositions and methods for the prophylaxis or treatment of viral diseases |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191203 Bcma Polypeptides And Uses Thereof |
| 07/30/2009 | US20090191198 Methods for blocking the interaction between nkp80 and its ligands |
| 07/30/2009 | US20090191194 Inhibition of protein kinase c alpha for the treatment of cardiovascular diseases |
| 07/30/2009 | US20090191191 Methods for the Modulation of IL-13 |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191184 DcR3 polypeptide, A TNFR homolog |
| 07/30/2009 | US20090191180 Use of Factor VIIa Analogues with Increased Activity |
| 07/30/2009 | US20090191179 Use of factor VIIa analogues with increased activity |
| 07/30/2009 | US20090191178 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 07/30/2009 | US20090191177 Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 |
| 07/30/2009 | US20090191176 Chondroitin sulfate synthesis promoter |
| 07/30/2009 | US20090191175 Therapeutic methods using peg-conjugated agents and devices for performing the same |
| 07/30/2009 | US20090191173 Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 |
| 07/30/2009 | US20090191170 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/30/2009 | US20090191168 Pregnancy-Induced Oligodendrocyte Precursor Cell Proliferation Regulated by Prolactin |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191162 Catecholamine Receptor Modulation |
| 07/30/2009 | US20090191160 Methods of producing pluripotent stem-like cells |
| 07/30/2009 | US20090191156 Gm-csf cosmeceutical compositions and methods of use thereof |
| 07/30/2009 | US20090191154 Assembly and folding of fc-interferon-beta fusion proteins |
| 07/30/2009 | US20090191153 Oximyl macrocyclic derivatives |
| 07/30/2009 | US20090191152 Intralymphatic chemotherapy drug carriers |
| 07/30/2009 | US20090191151 Triazole-containing macrocyclic hcv serine protease inhibitors |
| 07/30/2009 | US20090191150 Methods of treating infections using il-21 |
| 07/30/2009 | US20090191149 IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 07/30/2009 | US20090191148 Cytokine muteins |
| 07/30/2009 | US20090191147 Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191126 Peptide and multivalent peptide conjugate for diagnosis and treatment of vascular plaques |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | DE10252284B4 Neue Cyclopeptide, ihre Verwendung, diese enthaltende Arznei-, akarizide und insektizide New cyclic peptides, their use, containing the same drug, acaricidal and insecticidal |
| 07/30/2009 | CA2749985A1 Diagnostic and therapeutic uses of gelsolin in renal failure |
| 07/30/2009 | CA2713189A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 07/30/2009 | CA2713055A1 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 07/30/2009 | CA2713005A1 Difluorinated tripeptides as hcv serine protease inhibitors |
| 07/30/2009 | CA2712940A1 Heteroaryl-containing tripeptide hcv serine protease inhibitors |
| 07/30/2009 | CA2712807A1 Peptides, compositions, and uses thereof |
| 07/30/2009 | CA2712604A1 Iap inhibitors |
| 07/30/2009 | CA2712512A1 Use of serine protease inhibitors in the treatment of skin diseases |
| 07/30/2009 | CA2712078A1 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082748A1 Agent preparations and medicine capable of generating and containing thrombin |
| 07/29/2009 | EP2082747A2 Treatment for Alzeimer's disease |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2082052A2 Knockout mice for pro1105, pro1279 or pro1783 coding genes |
| 07/29/2009 | EP2081964A2 Alginate and alginate lyase compositions and methods of use |
| 07/29/2009 | EP2081957A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 07/29/2009 | EP2081956A2 Method of cell culture and method of treatment comprising a vepo protein variant |